Michal Minczuk
@mitogene.bsky.social
Prof. at University of Cambridge @mrc-mbu.bsky.social; co-founder of Pretzeltx.com
Thanks for organising @mrcmitocluster.bsky.social and @robpitceathly.bsky.social
April 15, 2025 at 10:13 AM
Thanks for organising @mrcmitocluster.bsky.social and @robpitceathly.bsky.social
It would not be possible without: Keira Turner, Chris Powell, @lindseyvanhaute.bsky.social Pedro Pinheiro, Felix Bubeck, Ellen Wiedtke, @ryanlab.bsky.social Dirk Grimm @mito-oncogene.bsky.social - Thank you!!
April 9, 2025 at 7:10 PM
It would not be possible without: Keira Turner, Chris Powell, @lindseyvanhaute.bsky.social Pedro Pinheiro, Felix Bubeck, Ellen Wiedtke, @ryanlab.bsky.social Dirk Grimm @mito-oncogene.bsky.social - Thank you!!
Many thanks to Abi Ghifari and Martin Ott @mitolab.bsky.social for featuring our paper in News & Views (and calling it a "decisive technical leap forward" in #MitochondrialDisease treatment development!) 🙌
www.embopress.org/doi/full/10....
www.embopress.org/doi/full/10....
A decisive technical leap forward for personalized medicine to treat mitochondrial diseases | EMBO Molecular Medicine
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.
www.embopress.org
April 9, 2025 at 7:10 PM
Many thanks to Abi Ghifari and Martin Ott @mitolab.bsky.social for featuring our paper in News & Views (and calling it a "decisive technical leap forward" in #MitochondrialDisease treatment development!) 🙌
www.embopress.org/doi/full/10....
www.embopress.org/doi/full/10....